AssetMark Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$706K Buy
12,836
+5,829
+83% +$320K ﹤0.01% 987
2025
Q1
$495K Buy
7,007
+2,054
+41% +$145K ﹤0.01% 988
2024
Q4
$326K Buy
4,953
+4,621
+1,392% +$304K ﹤0.01% 1022
2024
Q3
$23.3K Sell
332
-20,711
-98% -$1.46M ﹤0.01% 1467
2024
Q2
$1.73M Buy
21,043
+5,696
+37% +$469K 0.01% 650
2024
Q1
$1.34M Buy
15,347
+3,098
+25% +$271K ﹤0.01% 663
2023
Q4
$1.18M Buy
12,249
+6,340
+107% +$611K ﹤0.01% 642
2023
Q3
$523K Buy
5,909
+1,003
+20% +$88.7K ﹤0.01% 750
2023
Q2
$425K Buy
4,906
+1,203
+32% +$104K ﹤0.01% 753
2023
Q1
$360K Buy
3,703
+404
+12% +$39.3K ﹤0.01% 758
2022
Q4
$341K Buy
3,299
+1,040
+46% +$108K ﹤0.01% 752
2022
Q3
$191K Buy
2,259
+872
+63% +$73.7K ﹤0.01% 767
2022
Q2
$115K Buy
1,387
+1,008
+266% +$83.6K ﹤0.01% 803
2022
Q1
$29K Buy
379
+305
+412% +$23.3K ﹤0.01% 1012
2021
Q4
$7K Sell
74
-15
-17% -$1.42K ﹤0.01% 1189
2021
Q3
$7K Buy
89
+16
+22% +$1.26K ﹤0.01% 1089
2021
Q2
$6K Buy
73
+2
+3% +$164 ﹤0.01% 1042
2021
Q1
$5K Hold
71
﹤0.01% 1000
2020
Q4
$6K Hold
71
﹤0.01% 987
2020
Q3
$5K Buy
71
+4
+6% +$282 ﹤0.01% 975
2020
Q2
$8K Sell
67
-2
-3% -$239 ﹤0.01% 881
2020
Q1
$6K Sell
69
-3
-4% -$261 ﹤0.01% 1056
2019
Q4
$6K Sell
72
-19
-21% -$1.58K ﹤0.01% 1074
2019
Q3
$6K Buy
91
+2
+2% +$132 ﹤0.01% 1018
2019
Q2
$8K Sell
89
-38
-30% -$3.42K ﹤0.01% 994
2019
Q1
$11K Sell
127
-38
-23% -$3.29K ﹤0.01% 972
2018
Q4
$14K Sell
165
-6
-4% -$509 ﹤0.01% 944
2018
Q3
$17K Buy
171
+26
+18% +$2.59K ﹤0.01% 955
2018
Q2
$14K Buy
+145
New +$14K ﹤0.01% 985
2018
Q1
Sell
-31
Closed -$3K 1469
2017
Q4
$3K Buy
31
+23
+288% +$2.23K ﹤0.01% 1333
2017
Q3
$1K Buy
+8
New +$1K ﹤0.01% 1324
2017
Q1
Sell
-4
Closed 1280
2016
Q4
$0 Buy
+4
New ﹤0.01% 1253
2016
Q2
Sell
-13
Closed -$1K 1169
2016
Q1
$1K Hold
13
﹤0.01% 1100
2015
Q4
$1K Buy
+13
New +$1K ﹤0.01% 1173